Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Beadle

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Molecular Vision|August 10, 2012
A novel cytarabine crystalline lipid prodrug: hexadecyloxypropyl cytarabine 3',5'-cyclic monophosphate for proliferative vitreoretinopathyJae Suk Kim, James R Beadle, William R Freeman, et al.
Antiviral Chemistry & Chemotherapy|July 20, 2000
In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudineK Y Hostetler, J L Hammond, G D Kini, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Antiviral activities of oral 1-O-hexadecylpropanediol-3-phosphoacyclovir and acyclovir in woodchucks with chronic woodchuck hepatitis virus infectionK Y Hostetler, J R Beadle, W E Hornbuckle, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2006
Antiviral activities of novel 5-phosphono-pent-2-en-1-yl nucleosides and their alkoxyalkyl phosphonoestersHyunah Choo, James R Beadle, Earl R Kern, et al.
Microbiology Spectrum|November 24, 2021
Broad-Spectrum <i>In Vitro</i> Antiviral Activity of ODBG-P-RVn: An Orally-Available, Lipid-Modified Monophosphate Prodrug of Remdesivir Parent Nucleoside (GS-441524)Michael K Lo, Punya Shrivastava-Ranjan, Payel Chatterjee, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2007
Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infectionsGeorge R Painter, Merrick R Almond, Lawrence C Trost, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistanceJ L Hammond, D L Koontz, H Z Bazmi, et al.
Antiviral Research|June 1, 1996
Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitroK Y Hostetler, G D Kini, J R Beadle, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2024
Oral pharmacokinetics and efficacy of oral phospholipid remdesivir nucleoside prodrugs against SARS-CoV-2 in miceAaron F Carlin, James R Beadle, Jeremy Ardanuy, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitroStephanie L Williams-Aziz, Caroll B Hartline, Emma A Harden, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Molecular Vision|August 10, 2012
A novel cytarabine crystalline lipid prodrug: hexadecyloxypropyl cytarabine 3',5'-cyclic monophosphate for proliferative vitreoretinopathyJae Suk Kim, James R Beadle, William R Freeman, et al.
Antiviral Chemistry & Chemotherapy|July 20, 2000
In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudineK Y Hostetler, J L Hammond, G D Kini, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Antiviral activities of oral 1-O-hexadecylpropanediol-3-phosphoacyclovir and acyclovir in woodchucks with chronic woodchuck hepatitis virus infectionK Y Hostetler, J R Beadle, W E Hornbuckle, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2006
Antiviral activities of novel 5-phosphono-pent-2-en-1-yl nucleosides and their alkoxyalkyl phosphonoestersHyunah Choo, James R Beadle, Earl R Kern, et al.
Microbiology Spectrum|November 24, 2021
Broad-Spectrum <i>In Vitro</i> Antiviral Activity of ODBG-P-RVn: An Orally-Available, Lipid-Modified Monophosphate Prodrug of Remdesivir Parent Nucleoside (GS-441524)Michael K Lo, Punya Shrivastava-Ranjan, Payel Chatterjee, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2007
Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infectionsGeorge R Painter, Merrick R Almond, Lawrence C Trost, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistanceJ L Hammond, D L Koontz, H Z Bazmi, et al.
Antiviral Research|June 1, 1996
Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitroK Y Hostetler, G D Kini, J R Beadle, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2024
Oral pharmacokinetics and efficacy of oral phospholipid remdesivir nucleoside prodrugs against SARS-CoV-2 in miceAaron F Carlin, James R Beadle, Jeremy Ardanuy, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitroStephanie L Williams-Aziz, Caroll B Hartline, Emma A Harden, et al.
Pageof 9